Identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa in blood cultures: A multicenter performance evaluation of a three-color peptide nucleic acid fluorescence in situ hybridization assay

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2259-2261

  Della Latta, Phyllis ^a   Salimnia, Hossein ^b   Painter, Theresa ^c   Wu, Fann ^a   Procop, Gary W ^d   Wilson, Deborah A ^d   Gillespie, Wendy ^e   Mender, Alayna ^f   Crystal, Benjamin S ^f  

^a NewYork Presbyterian Hospital   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DETROIT MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f AdvanDx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE NUCLEIC ACID;

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE IN SITU HYBRIDIZATION; KLEBSIELLA PNEUMONIAE; LIMIT OF DETECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY;

BACTERIOLOGICAL TECHNIQUES; BLOOD; COLOR; ESCHERICHIA COLI; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KLEBSIELLA PNEUMONIAE; PEPTIDE NUCLEIC ACIDS; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY;

BACILLI (CLASS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 79957528296     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02250-10     Document Type: Article

References (10)

1. Alexander, B. D., E. D. Ashley, L. B. Reller, and S. D. Reed. 2006. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn. Microbiol. Infect. Dis. 54:277-282.
2. Forrest, G. N., et al. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol. 44:3381-3383.
3. Forrest, G. N., S. Mehta, E. Weekes, D. P. Lincalis, J. K. Johnson., and R. A. Venezia. 2006. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J. Antimicrob. Chemother. 58:154-158.
4. Gaynes, R., J. Edwards, and the National Nosocomial Infectious Surveillance System. 2005. Overview of nosocomial infections caused by gramnegative bacilli. Clin. Infect. Dis. 41:848-854.
5. Hansen, D. S., L. Leerbeck, H. Kofod, and B. Bruun. 2010. Rapid same-day identification of 69% of bacteria and yeast from positive blood culture bottles using five PNA FISH fluorescence in situ hybridization probes, abstr. P1804. Abstr. 20th ESCMID, Vienna, Austria, 10 to 13 April 2010.
6. Kang, C., et al. 2003. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin. Infect. Dis. 37:745-751.
7. Kang, C., et al. 2005. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob. Agents Chemother. 49:760-766.
8. Karlowsky, J. A., et al. 2004. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann. Clin. Microbiol. Antimicrob. 3:7.
9. Micek, S., et al. 2005. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob. Agents Chemother. 49:1306-1311.
10. Morgan, M., et al. 2010. Multicenter evaluation of a new shortened peptide nucleic acid fluorescence in situ hybridization procedure for species identification of select gram-negative bacilli from blood cultures. J. Clin. Microbiol. 48:2268-2270.